Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$0 Hold
1
﹤0.01% 766
2020
Q1
$0 Sell
1
-117
-99% -$5.6K ﹤0.01% 787
2019
Q4
$6K Hold
118
﹤0.01% 551
2019
Q3
$5K Hold
118
﹤0.01% 567
2019
Q2
$5K Hold
118
﹤0.01% 578
2019
Q1
$5K Sell
118
-1
-0.8% -$43 ﹤0.01% 578
2018
Q4
$5K Sell
119
-1
-0.8% -$44 ﹤0.01% 558
2018
Q3
$5K Hold
120
﹤0.01% 626
2018
Q2
$5K Hold
120
﹤0.01% 623
2018
Q1
$5K Hold
120
﹤0.01% 590
2017
Q4
$5K Buy
+120
New +$5.53K ﹤0.01% 669

Other funds holding SNY

TrueWealth LLC's SNY Position: Q2 2020 in Review

TrueWealth LLC held its Sanofi (SNY) position steady in Q2 2020 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #766.

TrueWealth LLC first reported a position in SNY in Q4 2017 and has held it in 11 quarters since. The position peaked at $6K in Q4 2019. 583 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

  • TrueWealth LLC held 1 share of Sanofi worth $0 as of Q2 2020.
  • TrueWealth LLC left its Sanofi share count unchanged in Q2 2020.
  • Sanofi made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #766 holding.
  • TrueWealth LLC first reported a position in Sanofi in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's Sanofi position peaked at $6K in Q4 2019.
  • 583 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.